Absci Corporation (ABSI) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Vancouver, WA, アメリカ. 現CEOは Sean McClain.
ABSI を有する IPO日 2021-07-22, 156 名の正社員, に上場 NASDAQ Global Select, 時価総額 $485.08M.
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
